MARCUZZI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 6.820
EU - Europa 4.232
AS - Asia 1.333
SA - Sud America 87
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 1
Totale 12.527
Nazione #
US - Stati Uniti d'America 6.800
PL - Polonia 2.429
SE - Svezia 484
SG - Singapore 453
CN - Cina 419
IT - Italia 312
UA - Ucraina 308
HK - Hong Kong 276
FI - Finlandia 118
DE - Germania 111
RU - Federazione Russa 109
TR - Turchia 89
BG - Bulgaria 77
BR - Brasile 72
IE - Irlanda 71
FR - Francia 62
GB - Regno Unito 46
VN - Vietnam 38
BE - Belgio 28
SN - Senegal 27
NL - Olanda 15
CA - Canada 14
CH - Svizzera 14
KR - Corea 13
EU - Europa 9
AT - Austria 8
IN - India 8
RO - Romania 8
ES - Italia 7
DK - Danimarca 6
A2 - ???statistics.table.value.countryCode.A2??? 4
AZ - Azerbaigian 4
IL - Israele 4
MA - Marocco 4
VE - Venezuela 4
CL - Cile 3
IQ - Iraq 3
JP - Giappone 3
MX - Messico 3
NG - Nigeria 3
PT - Portogallo 3
AL - Albania 2
AM - Armenia 2
AR - Argentina 2
CO - Colombia 2
DZ - Algeria 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
LT - Lituania 2
NO - Norvegia 2
PK - Pakistan 2
SA - Arabia Saudita 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BO - Bolivia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
ID - Indonesia 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 12.527
Città #
Warsaw 2.425
Fairfield 899
Woodbridge 840
Houston 669
Ann Arbor 625
Chandler 506
Ashburn 504
Seattle 429
Wilmington 406
Jacksonville 298
Cambridge 294
Singapore 276
Hong Kong 274
Princeton 136
Boardman 119
Trieste 108
Beijing 85
Dearborn 83
Sofia 77
Columbus 76
Izmir 72
Dublin 71
Moscow 47
Santa Clara 44
Dong Ket 36
San Diego 36
Falls Church 35
Helsinki 28
Dakar 27
Brussels 26
Grafing 26
Jinan 23
Des Moines 21
Hefei 20
Kunming 20
Phoenix 20
Shanghai 19
Washington 18
Nanjing 17
Hebei 15
Redwood City 15
Los Angeles 13
Dallas 11
Seoul 11
Bremen 10
Guangzhou 10
Milan 10
Toronto 10
Chicago 9
Munich 9
Nanchang 9
Fuzhou 8
Kocaeli 8
Bern 7
Fremont 7
Shenyang 7
São Paulo 7
Changsha 6
Chengdu 6
Edinburgh 6
New York 6
Taizhou 6
Venezia 6
Amsterdam 5
London 5
North Bergen 5
Nuremberg 5
Tianjin 5
Vienna 5
Zhengzhou 5
Andover 4
Ankara 4
Baku 4
Belo Horizonte 4
Berlin 4
Bologna 4
Brescia 4
Chongqing 4
Council Bluffs 4
Frankfurt am Main 4
Haikou 4
Norwalk 4
Pune 4
San Francisco 4
Tappahannock 4
Brøndby 3
Buffalo 3
Centro 3
Detroit 3
Dongguan 3
Düsseldorf 3
Fort Worth 3
Gorizia 3
Lagos 3
Leawood 3
Lisbon 3
Manchester 3
Mumbai 3
Nürnberg 3
Perugia 3
Totale 10.087
Nome #
Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease 377
To extinguish the fire from outside the cell or to shutdown the gas valve inside? Novel trends in anti-inflammatory therapies 366
Alendronate, a double-edged sword acting in the mevalonate pathway 353
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 350
Neuronal Dysfunction Associated with Cholesterol Deregulation. 341
Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway. 329
Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry 321
Type i interferon-mediated autoinflammation due to DNase II deficiency 320
Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage 316
Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17 315
Two‑gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results. 311
Repositioning Of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice 285
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 271
Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients 262
Clinical Genetic Testing of Periodic Fever Syndromes 246
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. 233
Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? 232
Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children. 203
Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. 198
A comparative analysis of serologic parameters and oxidative stress in osteoarthritis and rheumatoid arthritis: reply to Mishra and colleagues 198
Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011). 195
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches. 192
A common genetic background could explain early-onset Crohn's disease. 191
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes. 190
Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency 190
Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis. 187
Inflammation profile of four early onset Crohn patients. 185
Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. 184
Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets 182
Comments to the editor concerning the paper entitled "Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways" Shiekh Tanveer Ahmad et al. 181
Database tools in genetic diseases research. 176
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 173
Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype 171
Cytokine levels in the serum of healthy subjects. 171
Mevalonate kinase deficiency and IBD: shared genetic background 170
Evolutionary hypothesis of the Mevalonate Kinase Deficiency. 164
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 163
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. 162
Block of the Mevalonate Pathway Triggers Oxidative and Inflammatory Molecular Mechanisms Modulated by Exogenous Isoprenoid Compounds 161
Curcumin and inflammatory bowel disease: Potential andlimits of innovative treatments 160
Farnesyl and geranylgeranyl transferase inhibitors: an anti-inflammatory effect. Comment to "Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells" Haematologica. 2013;98(1):31-40 156
Putative modifier genes in mevalonate kinase deficiency 156
Serum amyloid A and cholesterol: a pivotal role on inflammation. 151
Letter: inflammatory bowel disease, complementary and alternative medicine, and genetics 147
Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line 142
Family history in early-onset inflammatory bowel disease 142
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis 134
null 130
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders. 125
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study 124
Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes 122
The Challenge of Next Generation Sequencing in a Boy with Severe Mononucleosis and EBV-related Lymphoma 118
Autoinflammatory syndromes and coeliac disease: One observation and two hypotheses 118
Microcapsule a doppio strato di polisaccaridiutilizzabili come veicoli per la somministrazione oraledi sostanze biologicamente attive 116
Presence of IL-9 in paired samples of human colostrum and transitional milk. 113
null 109
null 108
Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency 105
Mevalonate kinase deficiency: disclosing the role of mevalonate pathway modulation in inflammation. 104
Clarification of the pleiotropic effects of statins on mevalonate pathway and the feedback regulation of isoprenoids requires more comprehensive investigation. 104
New Mechanisms in Autoinflammatory Diseases 99
Mouse model of mevalonate kinase deficiency: comparison of cytokines and chemokines profile with human patients 88
null 86
TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide. 84
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 79
Role of vitamin D in the pathogenesis of atheromatosis 77
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. 74
Standard treatment–refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus-specific hyperimmune globulin 71
The effect of clodronate on a mevalonate kinase deficiency cellular model. 60
Post-Irradiation Hyperamylasemia Is a Prognostic Marker for Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Pediatric Population: A Retrospective Single-Centre Cohort Analysis 46
Mevalonate kinase deficiency and squalene synthase inhibitor (TAK-475): The balance to extinguish the inflammation 42
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 41
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 37
Systemic and neuronal inflammatory markers in a mouse model of mevalonate kinase deficiency: a strain-comparative study. 35
Lysozyme-containing chitosan-coated arginate microspheres for oral immunisation 20
Totale 12.838
Categoria #
all - tutte 31.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.712


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020468 0 0 0 0 0 0 0 0 0 152 199 117
2020/20211.820 173 150 150 186 185 185 166 127 118 190 67 123
2021/2022974 48 50 56 59 78 102 58 18 98 91 77 239
2022/20231.384 164 201 118 206 117 246 1 109 145 10 56 11
2023/2024805 33 57 56 54 81 99 160 148 14 9 56 38
2024/20251.149 26 80 159 173 170 106 154 57 208 16 0 0
Totale 12.838